These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34110506)

  • 1. Program Adaptations to Provide Harm Reduction Services During the COVID-19 Pandemic: A Qualitative Study of Syringe Services Programs in the U.S.
    Frost MC; Sweek EW; Austin EJ; Corcorran MA; Juarez AM; Frank ND; Prohaska SM; LaKosky PA; Asher AK; Broz D; Jarlais DCD; Williams EC; Glick SN
    AIDS Behav; 2022 Jan; 26(1):57-68. PubMed ID: 34110506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives.
    Austin EJ; Corcorran MA; Briggs ES; Frost MC; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Jarlais DCD; Williams EC; Glick SN
    Int J Drug Policy; 2022 Nov; 109():103825. PubMed ID: 35977459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responding to a surge in overdose deaths: perspectives from US syringe services programs.
    Frost MC; Austin EJ; Corcorran MA; Briggs ES; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC; Williams EC; Glick SN
    Harm Reduct J; 2022 Jul; 19(1):79. PubMed ID: 35854351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative study.
    Ude M; Behrends CN; Kelly S; Schackman BR; Clear A; Goldberg R; Gelberg K; Kapadia SN
    Harm Reduct J; 2023 Feb; 20(1):12. PubMed ID: 36732773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020.
    Behrends CN; Lu X; Corry GJ; LaKosky P; Prohaska SM; Glick SN; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC
    Drug Alcohol Depend; 2022 Mar; 232():109323. PubMed ID: 35124386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harm Reduction and Adaptations Among PWUD in Rural Oregon During COVID-19.
    Seaman A; Leichtling G; Stack E; Gray M; Pope J; Larsen JE; Leahy JM; Gelberg L; Korthuis PT
    AIDS Behav; 2021 May; 25(5):1331-1339. PubMed ID: 33471243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "We were building the plane as we were flying it, and we somehow made it to the other end": syringe service program staff experiences and well-being during the COVID-19 pandemic.
    Wang A; Jawa R; Mackin S; Whynott L; Buchholz C; Childs E; Bazzi AR
    Harm Reduct J; 2022 Jul; 19(1):78. PubMed ID: 35841101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Were Needles Everywhere?: Differing Views on Syringe Waste and Disposal Associated With Needs-Based Syringe Services Programs Among Community Partners and Persons Who Inject Drugs.
    Hershow RB; Love Pieczykolan L; Worthington N; Adams M; McDonald R; Wilson S; McBee S; Balleydier S; Curran KG
    Subst Use Misuse; 2024; 59(8):1174-1181. PubMed ID: 38509704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syringe Services Programs' Role in Ending the HIV Epidemic in the U.S.: Why We Cannot Do It Without Them.
    Broz D; Carnes N; Chapin-Bardales J; Des Jarlais DC; Handanagic S; Jones CM; McClung RP; Asher AK
    Am J Prev Med; 2021 Nov; 61(5 Suppl 1):S118-S129. PubMed ID: 34686281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ingenuity and resiliency of syringe service programs on the front lines of the opioid overdose and COVID-19 crises.
    Wenger LD; Kral AH; Bluthenthal RN; Morris T; Ongais L; Lambdin BH
    Transl Res; 2021 Aug; 234():159-173. PubMed ID: 33746108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the impact of the COVID-19 pandemic on syringe services programs in rural Kentucky.
    Glick JL; Grieb SM; Harris SJ; Weir BW; Smith KC; Puryear T; Hamilton White R; Allen ST
    Harm Reduct J; 2022 May; 19(1):47. PubMed ID: 35590373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Police officer attitudes towards syringe services programming.
    Sightes E; Ray B; Paquet SR; Bailey K; Huynh P; Weintraut M
    Drug Alcohol Depend; 2019 Dec; 205():107617. PubMed ID: 31707271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.
    Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM
    Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shifting the paradigm: physician-authorized, student-led efforts to provide harm reduction services amidst legislative opposition.
    McMullen TP; Naeim M; Newark C; Oliphant H; Suchard J; Banimahd F
    Subst Abuse Treat Prev Policy; 2021 Mar; 16(1):27. PubMed ID: 33761954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access to HIV, Viral Hepatitis, and Substance Use Disorder Treatment/Overdose Prevention Services: A Qualitative Analysis of Syringe Service Programs (SSPs) Serving Rural PWID.
    Carnes NA; Asher AK; Bohm MK; Bessler PA
    Subst Use Misuse; 2021; 56(13):1933-1940. PubMed ID: 34353216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syringe services programs: An examination of legal, policy, and funding barriers in the midst of the evolving opioid crisis in the U.S.
    Jones CM
    Int J Drug Policy; 2019 Aug; 70():22-32. PubMed ID: 31059965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colocating Syringe Services, COVID-19 Vaccination, And Infectious Disease Testing: Baltimore's Experience.
    Heidari O; Meyer D; Lowensen K; Patil A; O'Conor KJ; LaRicci J; Hunt D; Bocek AP; Cargill V; Farley JE
    Health Aff (Millwood); 2024 Jun; 43(6):883-891. PubMed ID: 38830163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health literacy and changes in pattern of drug use among participants at the Stockholm Needle Exchange Program during the COVID-19 pandemic.
    Lindqvist K; Wallmofeldt C; Holmén E; Hammarberg A; Kåberg M
    Harm Reduct J; 2021 May; 18(1):52. PubMed ID: 33971892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs.
    Kesten JM; Holland A; Linton MJ; Family H; Scott J; Horwood J; Hickman M; Telfer M; Ayres R; Hussey D; Wilkinson J; Hines LA
    Int J Drug Policy; 2021 Dec; 98():103391. PubMed ID: 34343945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Availability of and Obstacles to Providing COVID-19 Vaccinations at Syringe Services Programs in the United States, 2021.
    Des Jarlais DC; Behrends CN; Corcorran MA; Glick SN; Perlman DC; Kapadia SN; Lu X; Feelemyer J; LaKosky P; Prohaska SM; Schackman BR
    Public Health Rep; 2022; 137(6):1066-1069. PubMed ID: 36113105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.